DE69310721D1 - Zuckerderivate von makroliden - Google Patents

Zuckerderivate von makroliden

Info

Publication number
DE69310721D1
DE69310721D1 DE69310721T DE69310721T DE69310721D1 DE 69310721 D1 DE69310721 D1 DE 69310721D1 DE 69310721 T DE69310721 T DE 69310721T DE 69310721 T DE69310721 T DE 69310721T DE 69310721 D1 DE69310721 D1 DE 69310721D1
Authority
DE
Germany
Prior art keywords
pct
macrolids
sugar derivatives
sec
date
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69310721T
Other languages
English (en)
Other versions
DE69310721T2 (de
Inventor
Kevin Koch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of DE69310721D1 publication Critical patent/DE69310721D1/de
Application granted granted Critical
Publication of DE69310721T2 publication Critical patent/DE69310721T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
DE69310721T 1992-03-02 1993-01-28 Zuckerderivate von makroliden Expired - Fee Related DE69310721T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84433192A 1992-03-02 1992-03-02
PCT/US1993/000470 WO1993018050A1 (en) 1992-03-02 1993-01-28 Sugar derivatives of macrolides

Publications (2)

Publication Number Publication Date
DE69310721D1 true DE69310721D1 (de) 1997-06-19
DE69310721T2 DE69310721T2 (de) 1997-09-04

Family

ID=25292419

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69310721T Expired - Fee Related DE69310721T2 (de) 1992-03-02 1993-01-28 Zuckerderivate von makroliden

Country Status (14)

Country Link
US (1) US5747465A (de)
EP (1) EP0629209B1 (de)
JP (1) JP2563080B2 (de)
AT (1) ATE153027T1 (de)
AU (1) AU3586293A (de)
CA (1) CA2131372C (de)
DE (1) DE69310721T2 (de)
DK (1) DK0629209T3 (de)
ES (1) ES2102642T3 (de)
FI (1) FI107535B (de)
GR (1) GR3024048T3 (de)
IL (1) IL104817A0 (de)
MX (1) MX9301060A (de)
WO (1) WO1993018050A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP584198A0 (en) * 1998-09-14 1998-10-08 Fujisawa Pharmaceutical Co., Ltd. New use
EP1768662A2 (de) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Immunstimulatoren kleiner moleküle und assays für deren nachweis
JP2007519757A (ja) 2004-12-01 2007-07-19 テバ ジョジセルジャール ザ−トケルエン ムケド レ−スベニュタ−ルシャシャ−グ ピメクロリマスの調製方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1467383A (en) * 1974-06-12 1977-03-16 Farmaceutici Italia Daunomycin analogues
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
EP0346427B1 (de) * 1987-12-09 1995-03-29 FISONS plc Makrozyklische verbindungen
AU6286690A (en) * 1989-08-18 1991-04-03 Fisons Plc Macrocyclic compounds
IE904050A1 (en) * 1989-11-13 1991-05-22 Merck & Co Inc Aminomacrolides and derivatives having immunosuppressive¹activity
EP0466365A3 (en) * 1990-07-03 1992-04-15 Merck & Co. Inc. Novel immunosuppressant fermentation products of a microorganism

Also Published As

Publication number Publication date
CA2131372A1 (en) 1993-09-16
EP0629209B1 (de) 1997-05-14
DK0629209T3 (da) 1997-10-13
ATE153027T1 (de) 1997-05-15
MX9301060A (es) 1993-09-01
CA2131372C (en) 1998-07-14
DE69310721T2 (de) 1997-09-04
AU3586293A (en) 1993-10-05
GR3024048T3 (en) 1997-10-31
JP2563080B2 (ja) 1996-12-11
WO1993018050A1 (en) 1993-09-16
EP0629209A1 (de) 1994-12-21
FI944017A (fi) 1994-09-01
FI107535B (fi) 2001-08-31
ES2102642T3 (es) 1997-08-01
JPH07500352A (ja) 1995-01-12
US5747465A (en) 1998-05-05
IL104817A0 (en) 1993-06-10
FI944017A0 (fi) 1994-09-01

Similar Documents

Publication Publication Date Title
DE69622031T2 (de) INDOLDERIVATE ALS cGMP-PDE INHIBITOREN
KR950700333A (ko) 개량된 알파 인터페론 조성물 및 인간 말초혈 백혈구로부터의 제조 방법(improved alpha interferon composition and method for its production from human peripheral blood leukocytes)
HUP0002373A2 (hu) Glükagon antagonisták/inverz agonisták és ezeket tartalmazó gyógyászati készítmények
EE9900465A (et) Uued ühendid
FR2686084B1 (fr) Nouveaux derives de l'imidazole, leur preparation et leurs applications therapeutiques.
ATE185548T1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
FI972308A (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
DE3888466T2 (de) 6-Arylaminomethylchinolin-Derivate und ihre Verwendung als Antitumorwirkstoff.
FI944014A0 (fi) Makrolidien desosaminojohdannaiset immuunivastetta heikentävinä aineina ja sieniä vastustavina aineina
GR3025698T3 (en) NOVEL GABAa RECEPTOR SUBTYPES AND METHODS FOR SCREENING DRUG COMPOUNDS USING IMIDAZOQUINOXALINES AND PYRROLOPYRIMIDINES TO BIND TO GABAa RECEPTOR SUBTYPES.
DE3889974T2 (de) Pyrazol-Derivate und diese enthaltende Behandlungsmittel für cerebrovaskulare Krankheiten.
DK0686155T3 (da) Xanthinderivater som adenosin A1-receptor-antagonister
DE69612056T2 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
DE69310721D1 (de) Zuckerderivate von makroliden
HUP0100611A2 (hu) Triazin vegyületek, és ilyeneket tartalmazó gyógyszerkészítmények a központi idegrendszer elváltozásainak kezelésére
BG102404A (en) The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
AU3862997A (en) Stable derivatives of ubiquinole, processes for their production and pharmaceutical use thereof
NO984651D0 (no) Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet
MX9202595A (es) Derivado de nucleosido.
DE69012742D1 (de) Azolderivate und fungizide Medikamente, diese als wirkende Komponente enthaltend.
FR2697253B1 (fr) Dérivés de 2-aminopyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique.
RU95100512A (ru) Мазь для лечения кожных заболеваний
FR2699534B1 (fr) Dérivés de alpha-thiényl-pipéridine-1-éthanol, leur préparation et leur application en thérapeutique.
UA6640A (uk) Спосіб прогнозування загострення супутнього захворювання при активізації основної патології
DE68914886T2 (de) Mittel zur Behandlung von Raynaud's Krankheit.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee